ReachRxResearch
Home
Research
Sign Up
Study limitation
Back to Research Hub
  1. Home
  2. Research Hub
  3. Study limitation

To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission

Study limitation reported by the research below: “International survey responses may reflect heterogeneous practice guidelines and healthcare systems, reducing generalizability to any single clinical setting.”

Papers